222 related articles for article (PubMed ID: 19741151)
21. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
23. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
[TBL] [Abstract][Full Text] [Related]
24. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.
Huang M; Miao ZH; Zhu H; Cai YJ; Lu W; Ding J
Mol Cancer Ther; 2008 Jun; 7(6):1440-9. PubMed ID: 18566216
[TBL] [Abstract][Full Text] [Related]
25. The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway.
Tosti E; Waldbaum L; Warshaw G; Gross EA; Ruggieri R
J Biol Chem; 2004 Nov; 279(46):47652-60. PubMed ID: 15342622
[TBL] [Abstract][Full Text] [Related]
26. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
27. Far-infrared irradiation inhibits breast cancer cell proliferation independently of DNA damage through increased nuclear Ca
Cho DH; Lee HJ; Lee JY; Park JH; Jo I
J Photochem Photobiol B; 2021 Jun; 219():112188. PubMed ID: 33901880
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors.
Pires IM; Ward TH; Dive C
Br J Pharmacol; 2010 Mar; 159(6):1326-38. PubMed ID: 20128802
[TBL] [Abstract][Full Text] [Related]
29. Autophosphorylated residues involved in the regulation of human chk2 in vitro.
Gabant G; Lorphelin A; Nozerand N; Marchetti C; Bellanger L; Dedieu A; Quéméneur E; Alpha-Bazin B
J Mol Biol; 2008 Jul; 380(3):489-503. PubMed ID: 18538787
[TBL] [Abstract][Full Text] [Related]
30. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
31. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.
Busby EC; Leistritz DF; Abraham RT; Karnitz LM; Sarkaria JN
Cancer Res; 2000 Apr; 60(8):2108-12. PubMed ID: 10786669
[TBL] [Abstract][Full Text] [Related]
32. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
[TBL] [Abstract][Full Text] [Related]
33. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
Agner J; Falck J; Lukas J; Bartek J
Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
[TBL] [Abstract][Full Text] [Related]
34. Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation.
Ahn J; Prives C
J Biol Chem; 2002 Dec; 277(50):48418-26. PubMed ID: 12386164
[TBL] [Abstract][Full Text] [Related]
35. Chk2 activation and phosphorylation-dependent oligomerization.
Xu X; Tsvetkov LM; Stern DF
Mol Cell Biol; 2002 Jun; 22(12):4419-32. PubMed ID: 12024051
[TBL] [Abstract][Full Text] [Related]
36. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
37. Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.
Galal SA; Khairat SHM; Ali HI; Shouman SA; Attia YM; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Tabll A; El-Shenawy R; El Abd YS; Ramdan R; El Diwani HI
Eur J Med Chem; 2018 Jan; 144():859-873. PubMed ID: 29316526
[TBL] [Abstract][Full Text] [Related]
38. Role of CHK2 inhibitors in the cellular responses to ionizing radiation.
Zahmatkesh MH; Hosseinimehr SJ; Mahdiuni H
Mini Rev Med Chem; 2014; 14(10):812-8. PubMed ID: 25307309
[TBL] [Abstract][Full Text] [Related]
39. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
[TBL] [Abstract][Full Text] [Related]
40. Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor.
Massey AJ; Borgognoni J; Bentley C; Foloppe N; Fiumana A; Walmsley L
PLoS One; 2010 Oct; 5(10):e13123. PubMed ID: 20976184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
